Pilot Study to Evaluate the Safety and Efficacy of Ariva® Silver Wintergreen in Reducing Cigarette Craving in Smokers

Completed · Phase 1

Conditions studied: Tobacco Use Disorder, Smoking

In brief

Study to determine the safety and effectiveness of Ariva® Silver Wintergreen lozenge on reducing craving for a cigarette in daily smokers.

Key facts

Study ID

NCT01337830

Run by

Star Scientific, Inc

People needed

111

Starts

2010-10-01

Expected to finish

2010-10-01

Last updated by the study team

2014-10-24

Who can join

Age: 23 and older, up to 72. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• healthy adult smoker
• smoking for at least 5 years
• smoking at least one (1) pack of cigarettes a day
• interest in quitting smoking

You may not qualify if…

• known allergy to silver or silver salts
• pregnant or breast-feeding
• current drug or alcohol abuse, and/or history of drug or alcohol dependence within 3 months of study

Where it is running

• Comfort Inn — Martinsburg, West Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.